المؤلفون: Pieter Sonneveld, Meletios A. Dimopoulos, Meral Beksac, Bronno van der Holt, Sara Aquino, Heinz Ludwig, Sonja Zweegman, Thilo Zander, Elena Zamagni, Ruth Wester, Roman Hajek, Lucia Pantani, Luca Dozza, Francesca Gay, AnneMaria Cafro, Luca De Rosa, Annamaria Morelli, Henrik Gregersen, Nina Gulbrandsen, Petra Cornelisse, Rosella Troia, Stefania Oliva, Vincent van de Velden, KaLung Wu, Paula F. Ypma, Gerard Bos, Mark-David Levin, Luca Pour, Christoph Driessen, Annemiek Broijl, Alexandra Croockewit, Monique C. Minnema, Anders Waage, Cecilie Hveding, Niels W. C. J. van de Donk, Massimo Offidani, Giuseppe A. Palumbo, Andrew Spencer, Mario Boccadoro, Michele Cavo

المساهمون: Interne Geneeskunde, MUMC+: MA Hematologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Hematology, Immunology, CCA - Cancer Treatment and quality of life, Sonneveld P., Dimopoulos M.A., Beksac M., van der Holt B., Aquino S., Ludwig H., Zweegman S., Zander T., Zamagni E., Wester R., Hajek R., Pantani L., Dozza L., Gay F., Cafro A., De Rosa L., Morelli A., Gregersen H., Gulbrandsen N., Cornelisse P., Troia R., Oliva S., van de Velden V., Wu K., Ypma P.F., Bos G., Levin M.-D., Pour L., Driessen C., Broijl A., Croockewit A., Minnema M.C., Waage A., Hveding C., van de Donk N.W.C.J., Offidani M., Palumbo G.A., Spencer A., Boccadoro M., Cavo M.

المصدر: Sonneveld, P, Dimopoulos, M A, Beksac, M, van der Holt, B, Aquino, S, Ludwig, H, Zweegman, S, Zander, T, Zamagni, E, Wester, R, Hajek, R, Pantani, L, Dozza, L, Gay, F, Cafro, A M, De Rosa, L, Morelli, A, Gregersen, H, Gulbrandsen, N, Cornelisse, P, Troia, R, Oliva, S, van de Velden, V, Wu, K L, Ypma, P F, Bos, G, Levin, M D, Pour, L, Driessen, C, Broijl, A, Croockewit, A, Minnema, M C, Waage, A, Hveding, C, van de Donk, N W C J, Offidani, M, Palumbo, G A, Spencer, A, Boccadoro, M & Cavo, M 2021, ' Consolidation and Maintenance in Newly Diagnosed Multiple Myeloma ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 39, no. 32, pp. 3613-3622 . https://doi.org/10.1200/JCO.21.01045
Journal of Clinical Oncology, 39, 32, pp. 3613-3622
Journal of Clinical Oncology, 39, 3613-3622
Journal of Clinical Oncology, 39(32), 3613-3622. American Society of Clinical Oncology
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(32), 3613-3622. American Society of Clinical Oncology
Sonneveld, P, Dimopoulos, M A, Beksac, M, van der Holt, B, Aquino, S, Ludwig, H, Zweegman, S, Zander, T, Zamagni, E, Wester, R, Hajek, R, Pantani, L, Dozza, L, Gay, F, Cafro, A, De Rosa, L, Morelli, A, Gregersen, H, Gulbrandsen, N, Cornelisse, P, Troia, R, Oliva, S, van de Velden, V, Wu, K, Ypma, P F, Bos, G, Levin, M-D, Pour, L, Driessen, C, Broijl, A, Croockewit, A, Minnema, M C, Waage, A, Hveding, C, van de Donk, N W C J, Offidani, M, Palumbo, G A, Spencer, A, Boccadoro, M & Cavo, M 2021, ' Consolidation and Maintenance in Newly Diagnosed Multiple Myeloma ', Journal of Clinical Oncology, vol. 39, no. 32, JCO2101045, pp. 3613-3622 . https://doi.org/10.1200/JCO.21.01045

مصطلحات موضوعية: Oncology, Cancer Research, Neoplasm, Residual, Time Factors, THERAPY, Consolidation (business), Antineoplastic Combined Chemotherapy Protocols, IMPROVES, Lenalidomide/administration & dosage, Lenalidomide, Multiple myeloma, OUTCOMES, INDUCTION, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Middle Aged, OPEN-LABEL, Progression-Free Survival, DEXAMETHASONE, Europe, Residual, Multiple Myeloma, Human, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9], Adult, Dexamethasone/administration & dosage, medicine.medical_specialty, Time Factor, Adolescent, Multiple Myeloma/drug therapy, BORTEZOMIB, Newly diagnosed, Maintenance Chemotherapy, Young Adult, SDG 3 - Good Health and Well-being, Internal medicine, medicine, Humans, Aged, Neoplasm Staging, Antineoplastic Combined Chemotherapy Protocol, business.industry, STEM-CELL TRANSPLANTATION, medicine.disease, Consolidation Chemotherapy, LENALIDOMIDE MAINTENANCE, Bortezomib/administration & dosage, Neoplasm, CONSENSUS, business

وصف الملف: STAMPA

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d062212186695d034b375b07fa82bfad
https://research.vumc.nl/en/publications/2b32098e-ca08-476c-9883-09664c6f97bc

المؤلفون: Stephan Fuhrmann, Peter Brossart, Markus Munder, Mathias Hänel, Anja Seckinger, Katja Weisel, Hartmut Goldschmidt, Helga Bernhard, Jan Dürig, Anna Jauch, Martin Goerner, Christina Kunz, Hans-Walter Lindemann, Steffen Luntz, Ahmet H. Elmaagacli, Igor Wolfgang Blau, Hans Salwender, Maximilian Merz, Sandra Sauer, Marc S. Raab, Martin Hoffmann, Elias K. Mai, Kaya Miah, Axel Benner, Dirk Hose, Uta Bertsch, Christof Scheid

المساهمون: Hematology, Basic (bio-) Medical Sciences

المصدر: Leukemia

مصطلحات موضوعية: Adult, Male, Melphalan, Cancer Research, medicine.medical_specialty, Multiple Myeloma/drug therapy, Medizin, Myeloma, Induction Chemotherapy/mortality, Article, Bortezomib, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Lenalidomide/administration & dosage, Humans, Medicine, Prospective Studies, Adverse effect, Lenalidomide, Multiple myeloma, Aged, Aged, 80 and over, business.industry, Correction, High dose melphalan, Consolidation Chemotherapy/mortality, Induction Chemotherapy, Hematology, Middle Aged, Prognosis, medicine.disease, Stem-cell research, Consolidation Chemotherapy, Survival Rate, Transplantation, Oncology, Toxicity, Randomized controlled trials, Bortezomib/administration & dosage, Female, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Multiple Myeloma, business, Follow-Up Studies, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abdfae6314551f474fd5c284e7f37463
https://doi.org/10.1038/s41375-020-0976-9

المؤلفون: Martin Goerner, Markus Munder, Martin Hoffmann, Katja Weisel, Peter Brossart, Elias K. Mai, Anja Seckinger, Hans Salwender, Bernhard Rabold, Dirk Hose, Thomas Hielscher, Igor Wolfgang Blau, Uta Bertsch, Steffen Luntz, Ahmet H. Elmaagacli, Stefanie Huhn, Nicola Giesen, Hartmut Goldschmidt, Jens Hillengass, Marc S. Raab, Christina Kunz, Christof Scheid, Anna Jauch, Maximilian Merz, Diana Tichy, Barbara Hügle-Dörr, Hans-Walter Lindemann, Mathias Hänel, Helga Bernhard, Jan Dürig, Stephan Fuhrmann

المساهمون: Hematology, Basic (bio-) Medical Sciences

المصدر: Leukemia. 34:1853-1865

مصطلحات موضوعية: Male, 0301 basic medicine, Melphalan, Oncology, Cancer Research, Medizin, Dexamethasone, Cyclophosphamide/administration & dosage, Bortezomib, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Lenalidomide/administration & dosage, Medicine, Hematopoietic Stem Cell Transplantation/mortality, Prospective Studies, Lenalidomide, Multiple myeloma, education.field_of_study, Maintenance Chemotherapy/mortality, Remission Induction, Hazard ratio, Hematopoietic Stem Cell Transplantation, Hematology, Prognosis, Combined Modality Therapy, Thalidomide, Survival Rate, 030220 oncology & carcinogenesis, Female, Multiple Myeloma, medicine.drug, Dexamethasone/administration & dosage, Melphalan/administration & dosage, medicine.medical_specialty, Population, Transplantation, Autologous, Maintenance Chemotherapy, 03 medical and health sciences, Internal medicine, Internal Medicine, Humans, education, Cyclophosphamide, Survival rate, Aged, Thalidomide/administration & dosage, business.industry, Consolidation Chemotherapy/mortality, medicine.disease, Multiple Myeloma/pathology, Consolidation Chemotherapy, Transplantation, 030104 developmental biology, Bortezomib/administration & dosage, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, business, Follow-Up Studies

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37d3744d392b8b60be666bc6b8b4d70d
https://doi.org/10.1038/s41375-020-0724-1

المؤلفون: Maximilian Merz, Anna Jauch, Peter Brossart, Jan Duerig, Hartmut Goldschmidt, Dirk Hose, Steffen Luntz, Britta Besemer, Elias K. Mai, Ahmet H. Elmaagacli, Anja Seckinger, Markus Munder, Stephan Fuhrmann, Hans-Walter Lindemann, Uta Bertsch, Marc S. Raab, Igor Wolfgang Blau, Christian Jehn, Hans Salwender, Katja Weisel, Axel Benner, Kaya Miah, Mathias Haenel, Christof Scheid

المساهمون: Hematology, Basic (bio-) Medical Sciences

مصطلحات موضوعية: Oncology, Adult, Cancer Research, medicine.medical_specialty, Adolescent, Long term follow up, Injections, Subcutaneous, Administration, Intravenous/methods, Medizin, Multiple Myeloma/drug therapy, Antineoplastic Agents, Newly diagnosed, Maintenance Chemotherapy, Bortezomib, Induction Chemotherapy/methods, Internal medicine, Induction therapy, Medicine, Humans, Prospective Studies, Multiple myeloma, Aged, business.industry, hematology, Induction Chemotherapy, Middle Aged, medicine.disease, Antineoplastic Agents/administration & dosage, Injections, Subcutaneous/methods, Bortezomib/administration & dosage, young adult, Administration, Intravenous, business, Multiple Myeloma, medicine.drug, Follow-Up Studies

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c3e93f399758e8aa52c01b85b8ed62d
https://hdl.handle.net/20.500.14017/a78230dc-1b15-42b4-b98b-770e800164f1

المؤلفون: Kastritis E., Palladini G., Minnema M. C., Wechalekar A. D., Jaccard A., Lee H. C., Sanchorawala V., Gibbs S., Mollee P., Venner C. P., Lu J., Schonland S., Gatt M. E., Suzuki K., Kim K., Cibeira M. T., Beksac M., Libby E., Valent J., Hungria V., Wong S. W., Rosenzweig M., Bumma N., Huart A., Dimopoulos M. A., Bhutani D., Waxman A. J., Goodman S. A., Zonder J. A., Lam S., Song K., Hansen T., Manier S., Roeloffzen W., Jamroziak K., Kwok F., Shimazaki C., Kim J. -S., Crusoe E., Ahmadi T., Tran N., Qin X., Vasey S. Y., Tromp B., Schecter J. M., Weiss B. M., Zhuang S. H., Vermeulen J., Merlini G., Comenzo R. L., Bradley Augustson, Fiona Kwok, Peter Mollee, Simon Gibbs, Chantal Doyen, Greet Bries, Isabelle Vande Broek, Ka Lung Wu, Koen Theunissen, Koen Van Eygen, Michel Delforge, Nathalie Meuleman, Philip Vlummens, Angelo Maiolino, Breno Moreno de Gusmão, Carlos Eduardo Miguel, Edvan Crusoe, Fernanda Moura, Fernanda Seguro, Jandey Bigonha, Juliane Musacchio, Karla Zanella, Laura Garcia, Marcelo Eduardo Zanella Capra, Reijane Alves de Assis, Rosane Bittencourt, Vania Hungria, Walter Braga, Wolney Barreto, Christopher Venner, Donna Reece, Emilie Lemieux-Blanchard, Kevin Song, Michael Sebag, Selay Lam, Victor Zepeda, Haitao Zhang, Jianda Hu, Jin Lu, Juan Li, Songfu Jiang, Ting Niu, Wenming Chen, Xiaonong Chen, Zhen Cai, Zhou Fude, Maja Oelholm Vase, Morten Salomo, Niels Abildgaard, Alain Fuzibet, Anne-Marie Stoppa, Arnaud Jaccard, Bertrand Arnulf, Bruno Moulin, Bruno Royer, David Ghez, Denis Caillot, Dominique Chauveau, Franck Bridoux, Lauriane Clement-Filliatre, Lionel Karlin, Lotfi Benboubker, Mamoun Dib, Margaret Macro, Mohamad Mohty, Olivier Decaux, Olivier Hermine, Olivier Tournilhac, Philippe Moreau, Salomon Manier, Sylvain Choquet, Véronique Dorvaux, Alexander Carpinteiro, Axel Nogai, Britta Besemer, Christoph Roellig, Roland Fenk, Stefan Knop, Stefan Schönland, Timon Hansen, Argiris Symeonidis, Efstathios Kastritis, Gabor Mikala, Tamás Masszi, Zsolt Nagy, Celia Suriu, Hila Magen, Iuliana Vaxman, Lev Shvidel, Meir Preis, Moshe Gatt, Noa Lavi, Osnat Jarchowsky, Tamar Tadmor, Yael Cohen, Angelo Vacca, Giovanni Palladini, Mario Boccadoro, Maurizio Martelli, Maurizio Musso, Michele Cavo, Chihiro Shimazaki, Hiroyuki Takamatsu, Kazutaka Sunami, Kenshi Suzuki, Nagaaki Katoh, Shinsuke Iida, Takayuki Ikezoe, Tomoaki Fujisaki, Yuta Katayama, Chang Ki Min, Ho-Jin Shin, Jin Seok Kim, Jung Yong Hong, Ki Hyun Kim, Sung-Soo Yoon, Aline Ramirez, Alvaro Cabrera, Christian Ramos, David Gomez Almaguer, Deborah Martinez, Guillermo Ruiz, Helen Dayani Caballero, Juan Antonio Flores Jimenez, Annemiek Broijl, Laurens Nieuwenhuizen, Monique Minnema, Paula Ypma, Wilfried Roeloffzen, Dominik Dytfeld, Grzegorz Charlinski, Grzegorz Helbig, Krzysztof Jamroziak, Sebastian Grosicki, Wieslaw Jedrzejczak, Albert Oriol Rocafiguera, Elham Askari, Fernando Escalante Barrigon, Isabel Krsnik Castello, Javier De la Rubia Comos, Jesus Martin Sanchez, Joaquin Martinez Lopez, Jose Angel Hernandez Rivas, Luis Felipe Casado Montero, Maria Jesus Blanchard Rodriguez, Maria Teresa Cibeira Lopez, Maria Victoria Mateos Manteca, Marta Sonia Gonzalez Perez, Mercedes Gironella Mesa, Rafael Rios Tamayo, Ramon Lecumberri Villamediana, Ricarda Garcia Sanchez, Sunil Lakhwani, Yolanda Gonzalez, Hareth Nahi, Kristina Carlsson, Markus Hansson, Ulf-Henrik Mellqvist, Ali Unal, Burhan Ferhanoglu, Hayri Ozsan, Levent Undar, Mehmet Turgut, Mehmet Yilmaz, Meral Beksac, Muhlis Cem Ar, Muzaffer Demir, Sevgi Besisik, Ashutosh Wechalekar, Jamie Cavenagh, Jim Cavet, Mark Cook, Rachel Hall, Adam Waxman, Anuj Mahindra, Cesar Rodriguez Valdes, Christine Ye, Craig Reeder, Daphne Friedman, David Siegel, Divaya Bhutani, Edward Libby, Eva Medvedova, Frank Passero, Giada Bianchi, Giampaolo Talamo, Guido Tricot, Hans Lee, Heather Landau, Jan Moreb, Jason Valent, Jeffrey Matous, Jeffrey A Zonder, Jesus Berdeja, Jonathan Kaufman, Keith Stockerl-Goldstein, Keren Osman, Ketan Doshi, Kevin Barton, Larry Anderson, Manisha Bhutani, Mehmet Kocoglu, Michael Rosenzweig, Michael Schuster, Michaela Liedtke, Morie Gertz, Naresh Bumma, Natalie Callander, Raymond Comenzo, Robert Vescio, Roger Pearse, Sandy W Wong, Stacey A Goodman, Stefano Tarantolo, Taimur Sher, Tibor Kovacsovics, Tomer Mark, Vaishali Sanchorawala, William Bensinger

المساهمون: Role of intra-Clonal Heterogeneity and Leukemic environment in ThErapy Resistance of chronic leukemias (CHELTER), Université Clermont Auvergne (UCA), Kastritis E., Palladini G., Minnema M.C., Wechalekar A.D., Jaccard A., Lee H.C., Sanchorawala V., Gibbs S., Mollee P., Venner C.P., Lu J., Schonland S., Gatt M.E., Suzuki K., Kim K., Cibeira M.T., Beksac M., Libby E., Valent J., Hungria V., Wong S.W., Rosenzweig M., Bumma N., Huart A., Dimopoulos M.A., Bhutani D., Waxman A.J., Goodman S.A., Zonder J.A., Lam S., Song K., Hansen T., Manier S., Roeloffzen W., Jamroziak K., Kwok F., Shimazaki C., Kim J.-S., Crusoe E., Ahmadi T., Tran N., Qin X., Vasey S.Y., Tromp B., Schecter J.M., Weiss B.M., Zhuang S.H., Vermeulen J., Merlini G., Comenzo R.L., Bradley Augustson, Fiona Kwok, Peter Mollee, Simon Gibbs, Chantal Doyen, Greet Bries, Isabelle Vande Broek, Ka Lung Wu, Koen Theunissen, Koen Van Eygen, Michel Delforge, Nathalie Meuleman, Philip Vlummens, Angelo Maiolino, Breno Moreno de Gusmão, Carlos Eduardo Miguel, Edvan Crusoe, Fernanda Moura, Fernanda Seguro, Jandey Bigonha, Juliane Musacchio, Karla Zanella, Laura Garcia, Marcelo Eduardo Zanella Capra, Reijane Alves de Assis, Rosane Bittencourt, Vania Hungria, Walter Braga, Wolney Barreto, Christopher Venner, Donna Reece, Emilie Lemieux-Blanchard, Kevin Song, Michael Sebag, Selay Lam, Victor Zepeda, Haitao Zhang, Jianda Hu, Jin Lu, Juan Li, Songfu Jiang, Ting Niu, Wenming Chen, Xiaonong Chen, Zhen Cai, Zhou Fude, Maja Oelholm Vase, Morten Salomo, Niels Abildgaard, Alain Fuzibet, Anne-Marie Stoppa, Arnaud Jaccard, Bertrand Arnulf, Bruno Moulin, Bruno Royer, David Ghez, Denis Caillot, Dominique Chauveau, Franck Bridoux, Lauriane Clement-Filliatre, Lionel Karlin, Lotfi Benboubker, Mamoun Dib, Margaret Macro, Mohamad Mohty, Olivier Decaux, Olivier Hermine, Olivier Tournilhac, Philippe Moreau, Salomon Manier, Sylvain Choquet, Véronique Dorvaux, Alexander Carpinteiro, Axel Nogai, Britta Besemer, Christoph Roellig, Roland Fenk, Stefan Knop, Stefan Schönland, Timon Hansen, Argiris Symeonidis, Efstathios Kastritis, Gabor Mikala, Tamás Masszi, Zsolt Nagy, Celia Suriu, Hila Magen, Iuliana Vaxman, Lev Shvidel, Meir Preis, Moshe Gatt, Noa Lavi, Osnat Jarchowsky, Tamar Tadmor, Yael Cohen, Angelo Vacca, Giovanni Palladini, Mario Boccadoro, Maurizio Martelli, Maurizio Musso, Michele Cavo, Chihiro Shimazaki, Hiroyuki Takamatsu, Kazutaka Sunami, Kenshi Suzuki, Nagaaki Katoh, Shinsuke Iida, Takayuki Ikezoe, Tomoaki Fujisaki, Yuta Katayama, Chang Ki Min, Ho-Jin Shin, Jin Seok Kim, Jung Yong Hong, Ki Hyun Kim, Sung-Soo Yoon, Aline Ramirez, Alvaro Cabrera, Christian Ramos, David Gomez Almaguer, Deborah Martinez, Guillermo Ruiz, Helen Dayani Caballero, Juan Antonio Flores Jimenez, Annemiek Broijl, Laurens Nieuwenhuizen, Monique Minnema, Paula Ypma, Wilfried Roeloffzen, Dominik Dytfeld, Grzegorz Charlinski, Grzegorz Helbig, Krzysztof Jamroziak, Sebastian Grosicki, Wieslaw Jedrzejczak, Albert Oriol Rocafiguera, Elham Askari, Fernando Escalante Barrigon, Isabel Krsnik Castello, Javier De la Rubia Comos, Jesus Martin Sanchez, Joaquin Martinez Lopez, Jose Angel Hernandez Rivas, Luis Felipe Casado Montero, Maria Jesus Blanchard Rodriguez, Maria Teresa Cibeira Lopez, Maria Victoria Mateos Manteca, Marta Sonia Gonzalez Perez, Mercedes Gironella Mesa, Rafael Rios Tamayo, Ramon Lecumberri Villamediana, Ricarda Garcia Sanchez, Sunil Lakhwani, Yolanda Gonzalez, Hareth Nahi, Kristina Carlsson, Markus Hansson, Ulf-Henrik Mellqvist, Ali Unal, Burhan Ferhanoglu, Hayri Ozsan, Levent Undar, Mehmet Turgut, Mehmet Yilmaz, Meral Beksac, Muhlis Cem Ar, Muzaffer Demir, Sevgi Besisik, Ashutosh Wechalekar, Jamie Cavenagh, Jim Cavet, Mark Cook, Rachel Hall, Adam Waxman, Anuj Mahindra, Cesar Rodriguez Valdes, Christine Ye, Craig Reeder, Daphne Friedman, David Siegel, Divaya Bhutani, Edward Libby, Eva Medvedova, Frank Passero, Giada Bianchi, Giampaolo Talamo, Guido Tricot, Hans Lee, Heather Landau, Jan Moreb, Jason Valent, Jeffrey Matous, Jeffrey A Zonder, Jesus Berdeja, Jonathan Kaufman, Keith Stockerl-Goldstein, Keren Osman, Ketan Doshi, Kevin Barton, Larry Anderson, Manisha Bhutani, Mehmet Kocoglu, Michael Rosenzweig, Michael Schuster, Michaela Liedtke, Morie Gertz, Naresh Bumma, Natalie Callander, Raymond Comenzo, Robert Vescio, Roger Pearse, Sandy W Wong, Stacey A Goodman, Stefano Tarantolo, Taimur Sher, Tibor Kovacsovics, Tomer Mark, Vaishali Sanchorawala, William Bensinger

المصدر: New England Journal of Medicine, 385(1), 46-58. MASSACHUSETTS MEDICAL SOC
New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2021, 385 (1), pp.46-58. ⟨10.1056/NEJMoa2028631⟩
Kastritis, E, Palladini, G, Minnema, M C, Wechalekar, A D, Jaccard, A, Lee, H C, Sanchorawala, V, Gibbs, S, Mollee, P, Venner, C P, Lu, J, Schönland, S, Gatt, M E, Suzuki, K, Kim, K, Cibeira, M T, Beksac, M, Libby, E, Valent, J, Hungria, V, Wong, S W, Rosenzweig, M, Bumma, N, Huart, A, Dimopoulos, M A, Bhutani, D, Waxman, A J, Goodman, S A, Zonder, J A, Lam, S, Song, K, Hansen, T, Manier, S, Roeloffzen, W, Jamroziak, K, Kwok, F, Shimazaki, C, Kim, J-S, Crusoe, E, Ahmadi, T, Tran, N, Qin, X, Vasey, S Y, Tromp, B, Schecter, J M, Weiss, B M, Zhuang, S H, Vermeulen, J, Merlini, G, for the ANDROMEDA Trial Investigators & Abildgaard, N 2021, ' Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis ', The New England Journal of Medicine, vol. 385, no. 1, pp. 46-58 . https://doi.org/10.1056/NEJMoa2028631

مصطلحات موضوعية: Male, Treatment outcome, Immunoglobulin Light-chain Amyloidosis/drug therapy, CD38, Dexamethasone, Cyclophosphamide/administration & dosage, Bortezomib, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Medicine, CRITERIA, Immunoglobulin Light-chain Amyloidosis, ComputingMilieux_MISCELLANEOUS, Aged, 80 and over, biology, Amyloidosis, Antibodies, Monoclonal, [SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/Hematology, General Medicine, Middle Aged, 3. Good health, Treatment Outcome, 030220 oncology & carcinogenesis, Female, Antibody, Human, Adult, Dexamethasone/administration & dosage, ANTIBODY DARATUMUMAB, Immunoglobulin light chain, DIAGNOSIS, Antibodies, Monoclonal/administration & dosage, Disease-Free Survival, 03 medical and health sciences, Humans, Cyclophosphamide, Aged, Antineoplastic Combined Chemotherapy Protocol, business.industry, Antineoplastic Combined Chemotherapy Protocols/adverse effects, AL AMYLOIDOSIS, Daratumumab, Amyloid fibril, medicine.disease, Molecular biology, Immunoglobulin Light-chain Amyloidosi, biology.protein, Bortezomib/administration & dosage, business, 030215 immunology

وصف الملف: application/pdf; application/octet-stream; STAMPA

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b685c6c0877c79c6650b72aaec2ee26
https://research.rug.nl/en/publications/74938df3-de87-47e6-b870-977d2f5bae19

المؤلفون: Enrique M. Ocio, Angelo Michele Carella, Maria-Victoria Mateos, Argiris Symeonidis, Heather Oakervee, Raymond H. Banh, Chang-Ki Min, Roman Hájek, Richard Greil, Pieter Sonneveld, Shang-Yi Huang, Carmen Kahatt, Ivan Spicka, Nathalie Meuleman, Sonia Extremera, James D'Rozario, Paul Cannell, Sara Martinez, Meletios A. Dimopoulos, Heinz Ludwig, Vicente Alfaro

المساهمون: Hematology

المصدر: Annals of Hematology
Annals of Hematology, 98(9), 2139-2150. Springer-Verlag
Annals of hematology
Annals of hematology, 98 (9

مصطلحات موضوعية: Male, Gastroenterology, Dexamethasone, Bortezomib, 0302 clinical medicine, Multiple myeloma, Depsipeptides, Antineoplastic Combined Chemotherapy Protocols, Clinical endpoint, Depsipeptides -- administration & dosage, Lenalidomide, Aged, 80 and over, Hematology, General Medicine, Sciences bio-médicales et agricoles, Middle Aged, Thalidomide, Survival Rate, 030220 oncology & carcinogenesis, Original Article, Female, medicine.symptom, medicine.drug, Adult, medicine.medical_specialty, Thalidomide -- administration & dosage, Nausea, Peptides, Cyclic, Relapsed, Disease-Free Survival, 03 medical and health sciences, Refractory, Internal medicine, medicine, Plitidepsin, Humans, Aged, Lenalidomide -- administration & dosage, Multiple Myeloma -- drug therapy -- mortality, business.industry, medicine.disease, Dexamethasone -- administration & dosage, Antineoplastic Combined Chemotherapy Protocols -- administration & dosage, Bortezomib -- administration & dosage, business, Hématologie, 030215 immunology

وصف الملف: application/pdf; 1 full-text file(s): application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bca21caae1db2c673a339baafea4841c
https://doi.org/10.1007/s00277-019-03739-2

المؤلفون: Mateos, María-Victoria, Dimopoulos, Meletios A, Cavo, Michele, Suzuki, Kenshi, Jakubowiak, Andrzej, Knop, Stefan, Doyen, Chantal, Lucio, Paulo, Nagy, Zsolt, Kaplan, Polina, Pour, Ludek, Cook, Mark, Grosicki, Sebastian, Crepaldi, Andre, Liberati, Anna M, Campbell, Philip, Shelekhova, Tatiana, Yoon, Sung-Soo, Iosava, Genadi, Fujisaki, Tomoaki, Garg, Mamta, Chiu, Christopher, Wang, Jianping, Carson, Robin, Crist, Wendy, Deraedt, William, Nguyen, Huong, Qi, Ming, San-Miguel, Jesus, ALCYONE Trial Investigators

المساهمون: UCL - (MGD) Service d'hématologie, UCL - SSS/IREC/MONT - Pôle Mont Godinne, Clinical sciences, Hematology, Mateos, María-Victoria, Dimopoulos, Meletios A, Cavo, Michele, Suzuki, Kenshi, Jakubowiak, Andrzej, Knop, Stefan, Doyen, Chantal, Lucio, Paulo, Nagy, Zsolt, Kaplan, Polina, Pour, Ludek, Cook, Mark, Grosicki, Sebastian, Crepaldi, Andre, Liberati, Anna M, Campbell, Philip, Shelekhova, Tatiana, Yoon, Sung-Soo, Iosava, Genadi, Fujisaki, Tomoaki, Garg, Mamta, Chiu, Christopher, Wang, Jianping, Carson, Robin, Crist, Wendy, Deraedt, William, Nguyen, Huong, Ming, Qi, San-Miguel, Jesus for the ALCYONE Trial Investigators

المصدر: New England Journal of Medicine, Vol. 378, no. 6, p. 518-528 (2018)

مصطلحات موضوعية: Male, Oncology, Melphalan, Kaplan-Meier Estimate, Bortezomib, Prednisone/administration & dosage, 0302 clinical medicine, Prednisone, bortezomib, melphalan, prednisone, hemic and lymphatic diseases, Monoclonal, Antineoplastic Combined Chemotherapy Protocols, Multiple myeloma, Medicine (all), Standard treatment, antineoplastic agentbortezomibdaratumumabmelphalanmonoclonal antibodyprednisone, Antibodies, Monoclonal, General Medicine, Middle Aged, Intention to Treat Analysis, 3. Good health, Survival Rate, 030220 oncology & carcinogenesis, oncology, Female, Infection, Multiple Myeloma, medicine.drug, Adult, Melphalan/administration & dosage, medicine.medical_specialty, Multiple Myeloma/drug therapy, Infections, Antibodies, Monoclonal/administration & dosage, Antibodies, Disease-Free Survival, 03 medical and health sciences, Internal medicine, medicine, Humans, Survival rate, Aged, business.industry, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Daratumumab, Infections/chemically induced, medicine.disease, Follow-Up Studies, Transplantation, Bortezomib/administration & dosage, business, 030215 immunology

وصف الملف: ELETTRONICO

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ad05469cd382ea0c0c730507710cf6c
https://doi.org/10.1056/nejmoa1714678

المؤلفون: Igor Wolfgang Blau, Katja Weisel, Jan Duerig, Mathias Haenel, Roland Fenk, Uta Bertsch, Christina Kunz, Stefanie Huhn, Marc S. Raab, Hartmut Goldschmidt, Uwe M. Martens, Ullrich Graeven, Manfred Hensel, Stefan Fronhoffs, Jens Hillengass, Mohammed Wattad, Hans Salwender, Markus Munder, Anna Jauch, Hans-Walter Lindemann, Timon Hansen, Dirk Hose, Christof Scheid, Axel Benner, Mindaugas Andrulis, Michael Hundemer, Andrea Seidel-Glaetzer

المساهمون: Hematology, Basic (bio-) Medical Sciences

المصدر: BMC Cancer
BMC Cancer, Vol 19, Iss 1, Pp 1-11 (2019)

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, medicine.medical_treatment, Medizin, Dexamethasone, Bortezomib, Study Protocol, 610 Medical sciences Medicine, 0302 clinical medicine, Autologous stem-cell transplantation, Multiple myeloma, Clinical endpoint, Lenalidomide/administration & dosage, Prospective Studies, Elotuzumab, Lenalidomide, Melphalan, hematology, Hematopoietic Stem Cell Transplantation, Induction Chemotherapy, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, elotuzumab, Multiple Myeloma/therapy, Treatment Outcome, Research Design, 030220 oncology & carcinogenesis, Female, autologous stem cell transplant, Antibodies, Monoclonal, Humanized/administration & dosage, medicine.drug, Dexamethasone/administration & dosage, Adult, Melphalan/administration & dosage, medicine.medical_specialty, Antibodies, Monoclonal, Humanized, lcsh:RC254-282, Maintenance Chemotherapy, 03 medical and health sciences, Young Adult, Internal medicine, Genetics, medicine, Humans, Aged, Chemotherapy, business.industry, medicine.disease, Survival Analysis, Consolidation Chemotherapy, 030104 developmental biology, Quality of Life, Bortezomib/administration & dosage, business, high-dose chemotherapy

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18b58d1361d94b3c6f22e13502a6ffd2
http://europepmc.org/articles/PMC6537200

المؤلفون: Trung Hieu Do, Henrik Gregersen, Mary Jarden, Lene Kongsgaard Nielsen, Henrik Frederiksen, Niels Abildgaard, Ulf Christian Frølund, Ida Bruun Kristensen, Christen Lykkegaard Andersen, Tobias Wirenfeldt Klausen, Annette Juul Vangsted

المصدر: Nielsen, L K, Klausen, T W, Jarden, M, Frederiksen, H, Vangsted, A J, Do, T, Kristensen, I B, Frølund, U C, Andersen, C L, Abildgaard, N & Gregersen, H 2019, ' Clarithromycin added to bortezomib-cyclophosphamide-dexamethasone impairs health-related quality of life in multiple myeloma patients ', European Journal of Haematology, vol. 102, no. 1, pp. 70-78 . https://doi.org/10.1111/ejh.13175
Nielsen, L K, Klausen, T W, Jarden, M, Frederiksen, H, Vangsted, A J, Do, T, Kristensen, I B, Frølund, U C, Andersen, C L, Abildgaard, N & Gregersen, H 2019, ' Clarithromycin added to Bortezomib-Cyclophosphamide-Dexamethasone impairs health-related quality of life in multiple myeloma patients ', European Journal of Haematology, vol. 102, no. 1, pp. 70-78 . https://doi.org/10.1111/ejh.13175

مصطلحات موضوعية: Male, Denmark, Dexamethasone, Cyclophosphamide/administration & dosage, Bortezomib, 0302 clinical medicine, Clinical Protocols, Quality of life, Clarithromycin, Antineoplastic Combined Chemotherapy Protocols, Multiple myeloma, Induction Chemotherapy, Hematology, General Medicine, Middle Aged, multiple myeloma, Treatment Outcome, 030220 oncology & carcinogenesis, Female, Multiple Myeloma, medicine.drug, Adult, Dexamethasone/administration & dosage, medicine.medical_specialty, Cyclophosphamide, 03 medical and health sciences, Internal medicine, medicine, Humans, Multiple Myeloma/diagnosis, Adverse effect, Aged, Neoplasm Staging, clinical trials, business.industry, Antineoplastic Combined Chemotherapy Protocols/adverse effects, medicine.disease, Clarithromycin/administration & dosage, Denmark/epidemiology, Transplantation, Regimen, quality of life, Quality of Life, Bortezomib/administration & dosage, business, 030215 immunology, transplantation

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc9c9d7fbadba798ff49ae8eac979377
https://findresearcher.sdu.dk:8443/ws/files/146416826/Clarithromycin_added_to_Bortezomib_Cyclophosphamide_Dexamethasone....pdf

المؤلفون: Markus Munder, Matthias Zeis, Hartmut Goldschmidt, Anna Jauch, Thomas Hielscher, Elias K. Mai, Mathias Haenel, Christof Scheid, Peter Brossart, Anja Seckinger, Dirk Hose, Maximilian Merz, Jens Hillengass, Christian Gerecke, Hans Walter Lindemann, Baerbel Schurich, Igor Wolfgang Blau, Marc-Steffen Raab, Uta Bertsch, Christina Kunz, Jan Duerig, Hans Salwender, Katja Weisel

المساهمون: Hematology, Basic (bio-) Medical Sciences

المصدر: Haematologica. 101:e485-e487

مصطلحات موضوعية: medicine.medical_specialty, Peripheral Nervous System Diseases/chemically induced, Multiple Myeloma/complications, Medizin, Newly diagnosed, Neurotoxic agents, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, hemic and lymphatic diseases, Internal medicine, medicine, Humans, risk factors, Genetics(clinical), In patient, Online Only Articles, Multiple myeloma, Bortezomib, business.industry, Antineoplastic Agents/adverse effects, Hematology, medicine.disease, Surgery, Thalidomide, Clinical trial, Peripheral neuropathy, 030220 oncology & carcinogenesis, Bortezomib/administration & dosage, Induction Chemotherapy/adverse effects, business, 030215 immunology, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1faee40fdb1121975794e8ec8514b75
https://doi.org/10.3324/haematol.2016.151266